Picture of Amplia Therapeutics logo

ATX — Amplia Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Australia Stock Exchange release from AMPLIA THERAPEUT : Inhibition of FAK by AMP945 in Phase 1 Clinical Trial

Australia Stock Exchange release from AMPLIA THERAPEUT  ATX.AX : Inhibition of FAK by AMP945 in Phase 1 Clinical Trial

Recent news on Amplia Therapeutics

See all news